 |
|
Scientists find a key culprit in stroke brain cell damage
March 28, 2008Researchers have identified a key player in the killing of brain cells after a stroke or a seizure. The protein asparagine endopeptidase (AEP) unleashes enzymes that break down brain cells' DNA, scientists at Emory University School of Medicine have found.
The results are published in the March 28 issue of the journal Molecular Cell.
Finding drugs that block AEP may help doctors limit permanent brain damage following strokes or seizures, says senior author Keqiang Ye, PhD, associate professor of pathology and laboratory medicine at Emory.
When a stroke obstructs blood flow to part of the brain, the lack of oxygen causes a buildup of lactic acid, the same chemical that appears in the muscles during intense exercise. In addition, a flood of chemicals that brain cells usually use to communicate with each other over-excites the cells. Epileptic seizures can have similar effects.
While some brain cells die directly because of lack of oxygen, others undergo programmed cell death, a normal developmental process where cells actively destroy their own DNA.
"The mystery was: how do the acidic conditions trigger DNA damage?" Ye says. "This was a very surprising result because previously we had no idea that AEP was involved in this process."
AEP is a protease, a class of enzymes that cuts other proteins. AEP is also called legumain because of its relatives in plants, and is found at its highest levels in the kidney, says Ye.
He and his co-workers had suspected that another class of proteases called caspases, involved in programmed cell death, controlled DNA damage after a stroke.
At first, he and postdoctoral fellow Zhixue Liu, PhD, thought the results of a critical experiment that led them to AEP were an aberration because the experiment was performed under overly acidic conditions.
"But if you can repeat the mistake, it's not a mistake," Dr. Ye says, adding that follow-up work allowed them to set aside caspases as suspects and focus on AEP.
The researchers began by looking for proteins that stick to another protein called PIKE-L, which they previously had studied because of its ability to interfere with programmed cell death in brain cells.
They discovered that PIKE-L sticks to SET, a protein that other scientists had found regulates DNA-eating enzymes involved in programmed cell death. In addition, PIKE-L appears to protect SET from attack by AEP.
Liu and Ye found that a drug scientists use to mimic the acidic overload induced by stroke activates AEP, driving it to break down DNA in brain cells. In mice genetically engineered to lack AEP, both the drug and an artificial stroke resulted in reduced DNA damage and less brain cell death than in regular mice.
This outcome suggests "that AEP might be the major proteinase mediating this devastating process," the authors wrote.
Emory University
When a stroke obstructs blood flow to part of the brain, the lack of oxygen causes a buildup of lactic acid, the same chemical that appears in the muscles during intense exercise. In addition, a flood of chemicals that brain cells usually use to communicate with each other over-excites the cells. Epileptic seizures can have similar effects.
While some brain cells die directly because of lack of oxygen, others undergo programmed cell death, a normal developmental process where cells actively destroy their own DNA.
"The mystery was: how do the acidic conditions trigger DNA damage?" Ye says. "This was a very surprising result because previously we had no idea that AEP was involved in this process."
AEP is a protease, a class of enzymes that cuts other proteins. AEP is also called legumain because of its relatives in plants, and is found at its highest levels in the kidney, says Ye.
He and his co-workers had suspected that another class of proteases called caspases, involved in programmed cell death, controlled DNA damage after a stroke.
At first, he and postdoctoral fellow Zhixue Liu, PhD, thought the results of a critical experiment that led them to AEP were an aberration because the experiment was performed under overly acidic conditions.
"But if you can repeat the mistake, it's not a mistake," Dr. Ye says, adding that follow-up work allowed them to set aside caspases as suspects and focus on AEP.
The researchers began by looking for proteins that stick to another protein called PIKE-L, which they previously had studied because of its ability to interfere with programmed cell death in brain cells.
They discovered that PIKE-L sticks to SET, a protein that other scientists had found regulates DNA-eating enzymes involved in programmed cell death. In addition, PIKE-L appears to protect SET from attack by AEP.
Liu and Ye found that a drug scientists use to mimic the acidic overload induced by stroke activates AEP, driving it to break down DNA in brain cells. In mice genetically engineered to lack AEP, both the drug and an artificial stroke resulted in reduced DNA damage and less brain cell death than in regular mice.
This outcome suggests "that AEP might be the major proteinase mediating this devastating process," the authors wrote.
Emory University
Programmed Cell Current Events and Programmed Cell News RSSU of T researchers reveal Epstein-Barr virus protein contributes to cancer
Researchers at the University of Toronto have discovered that the EBNA1 protein of Epstein-Barr virus (EBV) disrupts structures in the nucleus of nasopharyngeal carcinoma (NPC) cells, thereby interfering with cellular processes that normally prevent cancer development.
Cardiac cell transplant studies show promise in cardiac tissue repair
Two studies published in the current issue of CELL TRANSPLANTATION (17:6) examine the efficacy of transplanting bone marrow cells (BMCs) for the repair of heart tissue.
Early trigger for type-1 diabetes found in mice, Stanford scientists report
Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins.
Yale undergrads' Amazon trip yields a treasure trove of diversity
A group of Yale undergraduates have discovered dozens of potentially beneficial bioactive microorganisms within plants they collected in the Amazon rain forest, including several so genetically distinct that they may be the first members of new taxonomical genera.
By amplifying cell death signals, scientists make precancerous cells self-destruct
When a cell begins to multiply in a dangerously abnormal way, a series of death signals trigger it to self-destruct before it turns cancerous. Now, in research to appear in the August 15 issue of Genes & Development, Rockefeller University scientists have figured out a way in mice to amplify the signals that tell these precancerous cells to die. The trick: Inactivating a protein that normally helps cells to avoid self-destruction.
NYU researchers demonstrate activity of mebendazole in metastatic melanoma
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.
Key to virulence protein entry into host cells discovered
Researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have identified the region of a large family of virulence proteins in oomycete plant pathogens that enables the proteins to enter the cells of their hosts.
Novel structure proteins could play a role in apoptosis
Isoforms from Novel Structure Proteins (NSP), a new family of genes discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology, could be involved in apoptosis or programmed cell death.
Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.
Refusal of suicide order: Why tumor cells become resistant
Cells with irreparable DNA damage normally induce programmed cell death, or apoptosis. However, this mechanism often fails in tumor cells so that transformed cells are able to multiply and spread throughout the body.
More Programmed Cell Current Events and Programmed Cell News Articles
 | Programmed Cell Death in Higher Plants The molecular mechanisms which determine whether the cells of a multicellular organism will live or commit suicide have become a popular field of research in biology during the last decade. Cell death research in the plant field has also been expanding rapidly in the past 5 years. This special volume of Plant Molecular Biology seeks to bring together examples of a diverse array of... |
 | When Cells Die: A Comprehensive Evaluation of Apoptosis and Programmed Cell Death When Cells Die A Comprehensive Evaluation of Apoptosis and Programmed Cell Death Edited by Richard A. Lockshin, Zahra Zakeri, and Jonathan L. Tilly Cell death is fast becoming one of the most dynamic areas of biological research -involving as it does the study of apoptosis and programmed cell death and the role these phenomena play in development and homeostasis on the one... |
 | Apoptosis: The Molecular Biology of Programmed Cell Death (Frontiers in Molecular Biology, 40) Apoptosis is a regulated form of cell demise that can be induced or blocked by groups of specific stimuli. Occurring in all living tissues, it is thought critical to the maintenance of homeostasis and is implicated in lowering susceptibility to tumour growth. Conversely, over-sensitivity to apoptotic triggers can cause cells to be lost inappropriately from tissues, as appears to occur in... |
 | Molecular Mechanisms of Programmed Cell Death This volume presents a current overview of key genes involved in the control of apoptosis research together with thoughts on future prospects and clinical applications. Top scientists from around the world wrote on current progresses to help establish and/or strengthen communications between scientists from the West and those in... |
 | Programmed Cell Death in Plants (Biological Sciences) by John Gray The recognition of cell death as an active process has changed the way in which biologists view living things. Geneticists are now re-evaluating long-known mutants, redesigning research strategies, and searching for new model systems. Plant biologists now apply this new perspective in the investigation of programmed cell death (PCD) in plants. For the first time in a single volume, Programmed... |
 | Programmed Cell Death Part B, Volume 446 (Methods in Enzymology) (Methods in Enzymology) |
 | Programmed Cell Death, Volume I (Advances in Cell Aging and Gerontology) by V. Rangnekar, S. Estus Apoptosis, or programmed cell death, is an adaptive form of cell death that plays a critical role in turnover of mitotic cells and various tissues in the adult, including epithelial cells, fibroblasts and various endocrine cells. Programmed cell death also plays a major role in development in organizing the body plan and molding intricate cellular structures such as nerve cell circuits in the... |
 | Programmed Cell Death by T. Cotter |
 | Programmed Cell Death In Animals and Plants (Experimental Biology Reviews) by Bryant et. al. |
 | Programmed Cell Death in Cancer Progression and Therapy (Advances in Experimental Medicine and Biology) (Advances in Experimental Medicine and Biology) Programmed cell death (PCD) plays pivotal roles in tumor progression, cancer therapeutics and resistance of tumor cells to therapy. With the discovery of key mechanisms that are involved in mediating PCD and in promoting resistance to therapy, design of therapeutic approaches for promoting tumor-selective cell death has risen dramatically. With this book, we give a comprehensive overview of the... |
| © 2008 BrightSurf.com |